US-listed company Sonnet BioTherapeutics postpones merger vote to December 2
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Foresight News reported that the US-listed company Sonnet BioTherapeutics has postponed its merger vote to December 2. Previously, it was reported that Sonnet BioTherapeutics would merge with Rorschach I LLC to form Hyperliquid Strategies and advance the HYPE reserve strategy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$83,917.82
-0.46%
Ethereum
ETH
$2,685.16
+0.00%
Tether USDt
USDT
$0.9998
+0.00%
BNB
BNB
$773.96
-0.43%
XRP
XRP
$1.56
+1.43%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$121.47
+4.21%
TRON
TRX
$0.3379
-0.66%
Zcash
ZEC
$1,532.71
-0.37%
Hyperliquid
HYPE
$91.91
-0.39%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now